Viridian Therapeutics, Inc.\DE - VRDN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 20, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.0% | 5,687,507 | View |
| Aug 20, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.0% | 5,687,507 | View |
| Aug 20, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.0% | 5,687,507 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 6.1% | 6,723,788 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 6.1% | 6,723,788 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 6.1% | 6,723,788 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 5.3% | 5,896,154 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Kynam Capital Management, LP | 5.7% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Kynam Capital Management GP, LLC | 5.7% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Yue Tang | 5.7% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G | T. Rowe Price Associates, Inc. | 5.2% | 5,748,426 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 3.25% | 3,592,740 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 3.25% | 3,592,740 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | David Kroin | 3.25% | 3,592,740 | View |
| Jun 26, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 5.1% | 5,633,788 | View |
| Jun 26, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 5.1% | 5,633,788 | View |
| Jun 26, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 5.1% | 5,633,788 | View |
| Jun 26, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 4.5% | 4,942,532 | View |
| May 15, 2026 | SCHEDULE 13G | Bellevue Group AG | 6.6% | 6,726,144 | View |
| May 15, 2026 | SCHEDULE 13G | Bellevue Asset Management AG | 6.6% | 6,726,144 | View |
| May 13, 2026 | SCHEDULE 13D/A | — | 19.99% | — | View |
| May 08, 2026 | SCHEDULE 13G | Deep Track Capital, LP | 5.3% | 5,417,660 | View |
| May 08, 2026 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 5.3% | 5,417,660 | View |
| May 08, 2026 | SCHEDULE 13G | David Kroin | 5.3% | 5,417,660 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.